L-glutamine Treatment in Patients With Diverticulosis

Diverticulosis, Colonic Clinical Trial

Official title:
A Pilot/Phase 1, Interventional, Open-label, Multi-center Study to Assess the Safety and Efficacy of L-glutamine Treatment in Patients With Diverticulosis

Status Completed

Clinical Trial Summary

The purpose of the study is evaluate the safety and efficacy of L-glutamine as a treatment for patients with diverticulosis.

Clinical Trial Description

After being informed about the study and potential risks, all patients giving written informed consent will undergo a 4 weeks screening period to determine eligibility for study entry. At Week 0, patients who meet eligibility requirements will be given L-glutamine (15 grams, twice daily) ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05106101
Study type	Interventional
Source	Emmaus Medical, Inc.
Contact
Status	Completed
Phase	Phase 1
Start date	July 19, 2019
Completion date	December 30, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03602677` - Indocyanine Green Fluorescence Imaging in Prevention of Colorectal Anastomotic Leakage	N/A
Completed	`NCT00535652` - Concentration of Ertapenem in Colorectal Tissue	Phase 4
Not yet recruiting	`NCT03465293` - Influence of Mechanical Bowel Preparation on GI Microbiota	N/A
Completed	`NCT03619538` - Interest of the Nefopam and PCA Morphine Combination for Postoperative Analgesia in Patients Undergoing Colon Surgery	N/A
Recruiting	`NCT04279821` - Prevalence of Segmental Colitis Associated With Colic Diverticulosis (SCAD)
Recruiting	`NCT02752360` - Biodegradable Stenting Anastomoses Versus Double-layer Hand Sutures for Reconstruction in Intestinal Anastomosis	Phase 1
Completed	`NCT00663247` - Mechanistic Randomized Controlled Trial (RCT) of Mesalazine in Symptomatic Diverticular Disease	N/A
Completed	`NCT05384925` - Prior Abdominal Surgery: A Potential Risk Factor for Colonic Diverticulosis or Diverticulitis